Learn More
Invitrogen™ VGLL4 Recombinant Rabbit Monoclonal Antibody (16H12L24)
Rabbit Recombinant Monoclonal Antibody
Supplier: Invitrogen™ 703012

Description
This antibody is predicted to react with Monkey, Horse, Cat. Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
Transcription cofactor vestigial-like protein 4 (VGLL4) acts as a specific coactivator for the mammalian TEFs.
Specifications
VGLL4 | |
Recombinant Monoclonal | |
0.5 mg/mL | |
PBS with 0.09% sodium azide; pH 7.4 | |
Q14135 | |
Vgll4 | |
Peptides corresponding to human VGLL4 [1) aa6-aa23 2) aa235-aa253]. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Immunocytochemistry | |
16H12L24 | |
Unconjugated | |
Vgll4 | |
BC048841; KIAA0121; Transcription cofactor vestigial-like protein 4; vestigial like 4; vestigial like 4 (Drosophila); vestigial like family member 4; Vestigial-like 4; vestigial-like family member 4; VGL-4; Vgll4 | |
Rabbit | |
Protein A | |
RUO | |
9686 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Safety and Handling
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.